Related Experiment Video

Updated: May 13, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Identification of novel AR-targeted microRNAs mediating androgen signalling through critical pathways to regulate

Wenjuan Mo1, Jiyuan Zhang, Xia Li

  • 1State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai, China.

Plos One
|March 2, 2013
PubMed

Insights

This study reveals how androgen receptor (AR) directly regulates specific microRNAs (miRNAs) in prostate cancer (PCa). These miRNAs, including miR-133b, influence cancer cell survival by modulating AR signaling pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are implicated in prostate cancer (PCa) development and progression.
  • The androgen receptor (AR) is a key driver in PCa, making its interaction with miRNAs crucial to understand.
  • Systematic elucidation of AR-miRNA associations and their molecular mechanisms is needed.

Purpose of the Study:

  • To investigate the dynamic genome-wide expression of mRNAs and miRNAs in response to androgen stimulation in PCa cells.
  • To identify AR target miRNAs and miRNA target mRNAs using novel scoring systems.
  • To uncover novel molecular mechanisms of AR-regulated miRNAs impacting PCa cell viability.

Main Methods:

  • Time-course microarrays were used to analyze mRNA and miRNA expression in LNCaP cells stimulated by androgen.
  • Response Score and Modulation Score were introduced to identify AR target miRNAs and miRNA target mRNAs, respectively.
  • Experimental validation was performed to confirm identified mechanisms.

Main Results:

  • Three novel AR target miRNAs (miR-19a, miR-27a, miR-133b) were identified.
  • miR-19a, miR-27a, and miR-133b were found to be directly up-regulated by AR.
  • These miRNAs repress various target genes, with miR-133b being essential for PCa cell survival and potentially overcoming androgen's growth restriction.

Conclusions:

  • This study elucidates novel mechanisms of miRNA-mediated AR signaling in PCa cell viability.
  • Identified miRNAs (miR-19a, miR-27a, miR-133b) represent potential therapeutic targets in prostate cancer.
  • Understanding these pathways provides insights into overcoming androgen's role in PCa progression.

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...